Musculoskeletal Disorders


Musculoskeletal Complaints in Children Recounted

October 25, 2017

Many nontraumatic low intensity complaints in the general population do not reach the threshold for consultation.

Research Offers a More Reliable Marker for IgG4-RD

November 29, 2016

Circulating IgG4/IgG ASC percentages of greater than five percent are a more sensitive and reliable marker for disease activity in patients with IgG4-RD, researchers report.

Dupuytren Referrals and Awareness Lacking, Survey Shows

November 30, 2011

Close to half (41%) of patients with Dupuytren contracture are not receiving prompt referral to a specialist, visiting their general practitioner (GP)/doctor almost 3 times before being referred, according to a Pfizer UK Limited survey of 700 GPs from 6 European countries.

First Insomnia Drug for Middle-of-the-Night Waking Receives FDA Approval

November 30, 2011

Intermezzo (zolpidem tartrate sublingual tablets) has received FDA approval for use as needed to manage insomnia.

Managing Systemic Sclerosis and Its Complications

October 11, 2011

Systemic sclerosis (SSc), or scleroderma, is a chronic connective-tissue disease that has a multitude of clinical manifestations. These authors offer a guide to recognition and pathogenesis, as well as counsel about management.

Modifiable Risk Factors Increase Total Joint Replacement Risk

October 05, 2011

Being overweight and reporting vigorous physical activity increase the risk of undergoing total joint replacement (TJR); severe osteoarthritis (OA) is the most common indicator for this procedure.